Promotion of oxidative stress by l-tryptophan in cerebral cortex of rats

Neurochemistry International

Volumn 49, Issue 1, 2006, Pages 87-93

  Feksa, Luciane Rosa ^a   Latini, Alexandra ^a,b   Rech, Virgínia Cielo ^a   Wajner, Moacir ^a,b   Dutra Filho, Carlos Severo ^a   Wyse, Angela Terezinha de Souza ^c   Wannmacher, Clovis Milton Duval ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c NONE

Author keywords

Antioxidant defenses; Hypertryptophanemia; Oxidative stress; Tryptophan

Indexed keywords

AMINO ACID; ANTIOXIDANT; CATALASE; GLUTATHIONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRYPTOPHAN;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CHEMOLUMINESCENCE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; ANTIOXIDANTS; CATALASE; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME INHIBITORS; FREE RADICALS; GLUTATHIONE; LIPID PEROXIDATION; LUMINESCENCE; MALE; NERVE DEGENERATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE I; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRYPTOPHAN;

EID: 33646347899     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.01.001     Document Type: Article

References (42)

1. Behl C., and Moosmann B. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. Biol. Chem. 383 3/4 (2002) 521-536
2. Bogdanov M.B., Andreassen O.A., Dedeoglu A., Ferrante R.J., and Beal M.F. Increased oxidative damage to DNA in a transgenic mouse of Huntington's disease. J. Neurochem. 79 (2001) 1246-11249
3. Browne R.W., and Armonstrong D. Reduced glutathione and glutathione disulfide. Methods Mol. Biol. 108 (1998) 347-352
4. Cadenas E., Simic M.G., and Sies H. Antioxidant activity of 5-hydroxytryptophan, 5-hydroxyindole, and DOPA against microsomal lipid peroxidation and its dependence on vitamin E. Free Radical Res. Commun. 6 (1989) 11-17
5. Cornelio A.R., Rodrigues-Júnior V., Wyse A.T.S., Dutra-Filho C.S., Wajner M., and Wannmacher C.M.D. Tryptophan reduces creatine kinase activity in the brain of rats. Int. J. Dev. Neurosci. 22 (2004) 95-101
6. Eastman C.L., and Guilarte T.R. Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line. Brain Res. 495 (1989) 225-231
7. Eastman C.L., and Guilarte T.R. The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine. Neurochem. Res. 15 (1990) 1101-1107
8. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
9. Evelson P., Travacio M., Repetto M., Escobar J., Llesury S., and Lissi E.A. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophy. 388 (2001) 261-266
10. Feksa L.R., Cornelio A., Dutra-Filho C.S., Wyse A.T.S., Wajner M., and Wannmacher C.M.D. The effects of the interactions between amino acids on pyruvate kinase activity from the brain cortex of young rats. Int. J. Dev. Neurosci. 23 (2005) 509-514
11. Fenton D.A., Wilkinson J.D., and Toseland P.A. Family exhibiting cerebellar-like ataxia, photosensitivity and shortness of stature-a new inborn error of tryptophan metabolism. J. R. Soc. Med. 76 (1983) 736-739
12. Forrest C.M., Mackay G.M., Stoy N., Egerton M., Christofides J., Stone T.W., and Darlington L.G. Tryptophan loading induces oxidative stress. Free Radical Res. 38 (2004) 1167-1171
13. González-Flecha B., Llesuy S., and Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver and muscle. Free Radical Biol. Med. 10 (1991) 93-100
14. Halliwell B., and Gutteridge J.M.C. Oxygen radicals and nervous system. Trends Neurosci. 8 (1996) 22-26
15. Halliwell B., and Gutteridge J.M.C. In: Halliwell B., and Gutteridge J.M.C. (Eds). Free Radicals in Biological and Medicine (1999), Oxford University Press, Oxford 188-276
16. Karelson E., Bogdanovic N., Garlind A., Winblad B., Zilmer K., Kullisaar T., Vihalemm T., Kairane C., and Zilmer M. The cerebrocortical areas in normal brain aging and in the Alzheimer's disease: noticeable difference in the lipid peroxidation level and in antioxidant defense. Neurochem. Res. 26 (2001) 353-361
17. Levy H.L. Hartnup disorder. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Diseases. 8th ed. (2001), McGraw-Hill, New York 1667-1724
18. Llesuy S.F., Milei J., Molina H., Boveris A., and Milei S. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4′-epiadriamycin in mice. Tumori 71 (1985) 241-249
19. Lissi E., Pascual C., and Del Castillo M.D. Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis. Free Radical Res. Commun. 17 (1992) 299-311
20. Lissi E., Salim-Hanna M., Pascual C., and Del Castillo M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radical Biol. Med. 18 (1995) 153-158
21. Lowry O.H., Rosebrough N.J., Lewis-Farr A., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
22. Méndez-Álvarez E., Soto-Otero R., Hermida-Aeijeiras A., López-Real A.M., and Labandeira-García J.L. Effects of aluminium and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease. Biochim. Biophys. Acta 1586 (2001) 155-168
23. Ogawa T., Matson N.R., Beal M.F., Myers R.H., Bird E.D., Milbury P., and Saso S. Kynurenine pathway abnormalities in Parkinson's disease. Neurology 42 (1992) 1702-1706
24. Pearson S.J., and Reynolds G.P. Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection. Increased concentrations in hepatic encephalopathy. J. Chromatogr. 565 (1991) 436-440
25. Perez-Severiano F., Rios C., and Segovia J. Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res. 862 (2000) 234-237
26. Perkins M.N., and Stone T.W. An iontophoretic investigation of the action of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 247 (1982) 184-187
27. Reznick A.Z., and Packer L. Free radicals and antioxidants in muscular neurological diseases and disorders. In: Poli G., Albano E., and Dianzani M.U. (Eds). Free Radicals: from Basic Science to Medicine (1993), Birkhäuser Verlag, Basel 425-437
28. Rubbo H., Radi R., Anselmi D., Kirk M., Barnes S., Butler J., Eiserich J.P., and Freeman B.A. Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation. Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate. J. Biol. Chem. 275 (2000) 10812-10818
29. Salih M.A., Bender D.A., and McCreanor G.M. Lethal familial pellagra-like skin lesion associated with neurologic and developmental impairment and the development of cataracts. Pediatrics 76 (1985) 787-793
30. Santus R., Patterson L.K., Filipe P., Morliere P., Hug G.L., Fernandes A., and Maziere J.C. Redox reactions of the urate radical/urate couple with the superoxide radical anion, the tryptophan neutral radical and selected flavonoids in neutral aqueous solutions. Free Radical Res. 35 (2001) 129-136
31. Sardar A.M., Bell J.E., and Reynolds G.P. Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients. J. Neurochem. 64 (1995) 932-935
32. Schwarcz R., Whetsell W.O., and Magano R.M. Quinolinic acid: an endogenous metabolite that causes axon-sparing lesions in rat brain. Science 219 (1983) 316-318
33. Sluis-Cremer N., Naidoo N., and Dirr H. Class-pi glutathione S-transferase is unble to regain its native conformation after oxidative inactivation by hydrogen peroxide. Eur. J. Biochem. 242 (1996) 301-307
34. Snedden W., Mellor C.S., and Martin J.R. Familial hypertryptophanemia, tryptophanuria and indolketonuria. Clin. Chim. Acta. 131 (1983) 247-256
35. Stone T.W. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64 (2001) 185-218
36. Stone T.W., and Darlington L.G. Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug Discovery 1 (2002) 609-620
37. Stone T.W., and Perkins M.N. Quinolinic acid: a potent endogenous excitant at amino acid receptors in the CNS. Eur. J. Pharmacol. 72 (1981) 411-412
38. Stoy n., Mackay G.M., Forrest C.M., Christofides J., Egerton M., Stone T.W., and Darlington L.G. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J. Neurochem. 93 (2005) 611-623
39. Stuart-Audette M., Blouquit Y., Faraggi M., Sicard-Roselli C., Houee-Levin C., and Jolles P. Re-evaluation of intramolecular long-range electron transfer between tyrosine and tryptophan in lysozymes. Evidence for the participation of other residues. Eur. J. Biochem. 270 (2003) 3565-3571
40. Watanabe S., Togashi S., Takahashi N., and Fukui T. l-tryptophan as an antioxidant in human placenta extract. J. Nutr. Sci. Vitaminol. (Tokyo) 48 (2002) 36-39
41. Wong P.W.K., Forman P., Tabahoff B., and Justice P. A defect in tryptophan metabolism. Pediatr. Res. 10 (1976) 725-730
42. Zhu W., and Fung P.C. The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl(4)-induced acute liver injury of mice. Free Radical Biol. Med. 29 (2000) 870-880